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Global redox proteome and phosphoproteome
analysis reveals redox switch in Akt
Zhiduan Su1,2,13, James G. Burchﬁeld 1,2,13, Pengyi Yang 1,3,13, Sean J. Humphrey 1,2, Guang Yang1,2,
Deanne Francis1,2, Sabina Yasmin4, Sung-Young Shin5,6, Dougall M. Norris1,2, Alison L. Kearney1,2,
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G. Gregory Neely1,2,9, Fatemeh Vafaee 1,3, Joyce Chiu10,11, Reichelle Yeo10,11, Philip J. Hogg 10,11,
Daniel J. Fazakerley 1,2, Lan K. Nguyen5,6, Serdar Kuyucak4 & David E. James1,2,12*
Protein oxidation sits at the intersection of multiple signalling pathways, yet the magnitude
and extent of crosstalk between oxidation and other post-translational modiﬁcations remains
unclear. Here, we delineate global changes in adipocyte signalling networks following acute
oxidative stress and reveal considerable crosstalk between cysteine oxidation and
phosphorylation-based signalling. Oxidation of key regulatory kinases, including Akt, mTOR
and AMPK inﬂuences the ﬁdelity rather than their absolute activation state, highlighting an
unappreciated interplay between these modiﬁcations. Mechanistic analysis of the redox
regulation of Akt identiﬁed two cysteine residues in the pleckstrin homology domain (C60
and C77) to be reversibly oxidized. Oxidation at these sites affected Akt recruitment to the
plasma membrane by stabilizing the PIP3 binding pocket. Our data provide insights into the
interplay between oxidative stress-derived redox signalling and protein phosphorylation
networks and serve as a resource for understanding the contribution of cellular oxidation to a
range of diseases.
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Reactive oxygen species (ROS) modulate cell signalling andprotein function via reversible protein oxidation1–4. Indeed,the activity of kinases and phosphatases can be altered by
redox-mediated post-translational modiﬁcations (PTMs), provid-
ing a link between ROS, phosphorylation-based signalling (phos-
pho-signalling)1,5–8 and physiological processes including cell
growth and proliferation4. However, excessive ROS, or oxidative
stress, is a causative factor in several diseases including diabetes,
atherosclerosis, and cancer3,9–12. This is considered to largely
result from inappropriate crosstalk between ROS and phospho-
signalling13,14. Despite this, there remains a paucity of systematic
studies dissecting the impact of ROS on cell signalling networks.
Reactive thiol groups on cysteine residues switch between
reduced and oxidized states in response to redox ﬂuctuations15–18.
ROS-dependent cysteine modiﬁcations are either reversible (e.g.
disulﬁde bonds, S-acylation, S-glutathionylation, S-nitrosylation, S-
sulfenylation, S-sulfhydration and sulﬁnic acid) or irreversible
(such as sulfonic acid)19. Reversible modiﬁcations can alter protein
structure and function2,20–22, with functional roles characterised in
several studies23,24. However, modiﬁcation of speciﬁc cysteines can
have diverse outcomes depending on the target and type of
modiﬁcation25, and the impact of most ROS-induced protein
modiﬁcations on cell signalling remains largely unexplored.
We have developed a simple model for studying widespread
cellular oxidation based on inhibition of the two major thiol-
based antioxidant systems (glutathione and thioredoxin)26. This
model allows ROS effects to be studied without the complex
phenotypes that may occur in disease-speciﬁc models27. This
model also has advantages over treatments like paraquat28, since
ROS are produced from endogenous locations.
Here we combine global analyses of the phosphoproteome,
cysteine redox proteome, and total proteome of adipocytes to
obtain a comprehensive view of global signalling network rewir-
ing during oxidative stress. Our analysis reveals complex remo-
delling of the phosphoproteome in response to widespread
oxidative stress-induced cysteine oxidation. Among the changes,
we identify oxidation of critical cysteine residues in the Ser/Thr
kinase Akt that are essential for its plasma membrane (PM)-
recruitment and activation.
Results
The adipocyte redox proteome. We measured the proteome and
redox proteome of adipocytes treated with either carmustine
(BCNU) alone or in combination with auranoﬁn (AF) for 2 or
24 h (Fig. 1a, Supplementary Fig. 1a). BCNU/AF impaired adi-
pocyte cellular antioxidant defences, indicated by increased per-
oxiredoxin 2 and peroxiredoxin 3 dimers (Fig. 1b)26.
We measured 13,451 reversibly oxidized cysteines (median
coefﬁcient of variation (CV) of 12.2% (Fig. 1c)), with 8,991 detected
in at least two replicates (Supplementary Data 1), and treatment
groups clustered distinctly by principal component analysis (PCA,
Fig. 1d). Of these, only ~12% (1550) were previously reported
(annotated in UniProt Knowledgebase; Supplementary Data 2).
The efﬁcacy of glutathione reducatase (Gsr) inhibition by BCNU
was apparent due to decreased oxidation of C54 and C59 on Gsr
(isoform 2) at all time points29,30 (Supplementary Data 3).
Similarly, C90 and C93 on mitochondrial thioredoxin (Txn2),
C48 on mitochondrial peroxiredoxin-5 (Prdx5) and C32 and C35
on thioredoxin (Txn) were oxidized under BCNU/AF treatment,
consistent with AF-mediated inhibition of thioredoxin reductase31
(Supplementary Data 3).
7451 proteins were quantiﬁed (Supplementary Data 4), of
which 4528 and 4204 were identiﬁed in all biological replicates of
BCNU and BCNU/AF treatments, respectively (median CV 6.2%,
Supplementary Fig. 1b, c). BCNU/AF treatment (24 h) resulted in
increased expression of 174 proteins and decreased expression of
1161 proteins (absolute fold change > 1.5, adjusted p < 0.05 by
moderated t-test), whereas 2 h treatment had minimal effect on
the proteome (Supplementary Fig. 1d and Supplementary Data 5).
As such, redox measurements following treatment for 24 h were
normalized to protein abundance.
Treatment with BCNU or BCNU/AF for 2 h increased global
cysteine oxidation (p < 0.0001 by moderated t-test, Fig. 1e).
Cysteine oxidation decreased in the 24 h BCNU treated cells (p <
0.0001 by moderated t-test, Fig. 1e), suggesting a compensatory
antioxidant response26. In contrast, cysteine oxidation increased
with 24 h BCNU/AF from 1,848 to 8,372 differentially oxidized
peptides (p < 0.0001 by moderated t-test from limma R package,
Fig. 1e and Supplementary Data 3). These data suggest worsening
oxidative stress in response to inhibition of both major cellular
antioxidant defence mechanisms for 24 h.
Direction analysis32 identiﬁed 330 oxidized peptides from 291
proteins that were oxidized in both 2 and 24 h BCNU/AF
treatments, that likely represent cysteines most sensitive to
oxidative stress (p < 0.01 by direction analysis32, Fig. 1f, Supple-
mentary Data 3). 60 of these were mitochondrial proteins which
was expected due to the higher pH in mitochondria, favouring the
reactivity of cysteine thiolates24,33, and because mitochondria are
a primary source of ROS34. Gene ontology (GO) enrichment
analysis of the 291 oxidized proteins revealed signiﬁcant
enrichment in ROS metabolic processes, translation, proteolysis,
protein phosphorylation and signalling (Fig. 1g).
The oxidative stress-regulated phosphoproteome. We next
quantiﬁed global changes in the adipocyte phosphoproteome
using the EasyPhos workﬂow35,36. Acute oxidative-stress treat-
ments (1 and 2 h) were employed to avoid large changes in
protein abundance. Cells were treated with BCNU/AF with and
without insulin to activate growth-factor signalling networks of
relevance to adipocytes. We identiﬁed more than 23,000 unique
phosphorylation events in 6,079 proteins (Fig. 2a, Supplementary
Data 6), with highly reproducible phosphopeptide quantiﬁcation
across conditions (Supplementary Fig. 2a, b). Since BCNU alone
had limited inﬂuence on key signalling pathways and peptide
oxidation (Supplementary Fig. 2c, Supplementary Data 3), we
focused on adipocytes incubated with BCNU/AF. PCA revealed
clear separation of both insulin stimulation in the ﬁrst principal
component (PC1), and a time-dependent separation of oxidative
stress in the second (PC2, Fig. 2b). Compared to non-insulin
stimulated cells, we observed a reduction in sample separation in
the second component (PC2) upon insulin stimulation, indicating
that the impact of oxidative stress on the phosphoproteome may
be counteracted by insulin stimulation (Fig. 2b).
In the absence of insulin, BCNU/AF treatment for 1 h resulted
in up-regulation of 214 and down-regulation of 799 phosphosites
and 2 h treatment resulted in up-regulation of 509 and down-
regulation of 1586 sites (absolute fold change > 1.5, adjusted p <
0.05 by moderated t-test, Fig. 2c, Supplementary Fig. 2d, e,
Supplementary Data 7). Interestingly, oxidative stress caused
greater dephosphorylation than phosphorylation and this was
most pronounced in non-insulin stimulated cells (Fig. 2c). As
observed by PCA (Fig. 2b), insulin attenuated oxidative-stress
induced changes in global phosphorylation (Fig. 2c, Supplemen-
tary Fig. 2f, Supplementary Data 7). This was particularly
apparent with phosphorylation sites that were down-regulated
by oxidative-stress, consistent with a degree of reciprocity
between these processes. Extended BCNU/AF treatment (2 h)
increased the number of oxidative-stress regulated phosphosites
markedly (Fig. 2c, d, Supplementary Data 7), indicating that
prolonged stress doesn’t simply increase the magnitude of change
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in protein phosphorylation but with increased time of exposure to
oxidative stress there is a much more vast impact on the
phosphoproteome than observed after acute exposure. Gene
ontology enrichment analysis of proteins regulated by 2 h BCNU/
AF treatment revealed the over-representation of several signal-
ling pathways including insulin, mitogen-activated protein kinase
(MAPK), receptor tyrosine-protein kinase ErbB (ErbB), mam-
malian target of rapamycin (mTOR), 5′ AMP-activated protein
kinase (AMPK) and HIF-1 signalling (Fig. 2e). Collectively, these
data indicate multiple phospho-signalling networks contain
oxidant-sensitive proteins, suggesting that our dataset may allow
us to identify key protein oxidation events that ﬁne tune
signalling through these major signalling nodes.
Crosstalk of oxidative stress and phospho-signalling network.
Integrative analysis of our multi-omics datasets revealed protein
oxidation to be negatively correlated with protein abundance
following 24 h BCNU/AF treatment (r=−0.37, p < 2.2e-16 by
Pearson’s correlation, Supplementary Fig. 3a). This was more
pronounced when only considering annotated kinases and sub-
strates (r=−0.42, p < 2.2e-16 by Pearson’s correlation,
Supplementary Fig. 3b). This suggests that long-term protein
oxidation negatively inﬂuences protein abundance, presumably
due to proteasome-mediated protein degradation37–39. No cor-
relation was observed between protein oxidation and phosphor-
ylation with 2 h BCNU/AF treatment either globally (r= 0.02,
p= 0.45 by Pearson’s correlation, Supplementary Fig. 3a) or for
annotated kinases and substrates (r= 0.02, p= 0.76 by Pearson’s
correlation, Supplementary Fig. 3b), suggesting changes in pro-
tein phosphorylation in response to BCNU/AF treatment were
unlikely a direct result of oxidation of these proteins.
We hypothesised that global phosphorylation changes result
from oxidative stress-induced changes in the activity of upstream
kinases and/or phosphatases. To test this, we examined the
crosstalk between oxidation and insulin signalling (Fig. 3a),
speciﬁcally the kinases Akt, mTOR and AMPK. These kinases all
had signiﬁcantly altered levels of cysteine oxidation following
BCNU/AF treatment (Fig. 3a, Supplementary Fig. 3c) and the
phosphorylation of a large number of their known and predicted
substrates40 were altered upon BCNU/AF treatment (predomi-
nantly down-regulated) compared to controls (Fig. 3b, Supple-
mentary Fig. 3d), consistent with the hypothesis that oxidation of
these kinases regulates their activity.
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Fig. 1 Redox proteomic analysis of adipocytes. a Experimental design of the redox proteomic analysis of adipocytes treated with BCNU or BCNU/AF.
b Immunoblotting of Prdx2/3 dimerisation. Prdx2/3 dimer/monomer ratio was measured. Data were shown as mean ± SEM from n= 4, ****p < 0.0001 by
one-way ANOVA. c Coefﬁcient of variation of the quantiﬁed redox proteome. Boxes capture lower quartile and upper quartile with median displayed as a
horizontal line in the middle; whiskers are min and max. d Principal component analysis of the redox proteome. e Relative intensities of the quantiﬁed redox
proteome. f Direction-based integrative analysis of redox proteome between 2 h and 24 h treatment of BCNU/AF (see “Methods”). Signiﬁcantly oxidized
peptides were coloured (p < 0.01, by modiﬁed Pearson’s Correlation Test32). g Direction pathway analysis of signiﬁcantly oxidized proteins under both the
2 h and 24 h treatment of BCNU/AF (corresponding to the red dots in Fig. 1f) using gene ontology.
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Akt is activated by phosphorylation at two sites, T309 and
S474, by the upstream kinases PDK1 and mTORC2, respectively.
We observed oxidation of Akt at C77 (Fig. 3a and Supplementary
Data 3) and hyper-phosphorylation of T309 under both basal and
insulin-stimulated conditions (Fig. 3a, Supplementary Data 7)
raising the possibility that oxidation may regulate Akt activation.
BCNU/AF treatment had no effect on Akt S474 phosphorylation
either with or without insulin stimulation (Supplementary
Data 7). Akt was activated by insulin as indicated by increased
phosphorylation of a range of its substrates (Fig. 3b, Supplemen-
tary Fig. 2g, Supplementary Data 7). However, insulin-stimulated
phosphorylation of 11 Akt substrates was inhibited by
oxidative stress (Fig. 3b, Supplementary Data 7) despite hyper-
phosphorylation of Akt T309. While the reduction in phosphor-
ylation of these Akt substrates was more pronounced after 2 h of
BCNU/AF treatment (Fig. 3b, c), it was notable that not all Akt
substrates were inﬂuenced by oxidative stress. This suggests that
oxidative stress modiﬁes Akt signalling in a substrate-speciﬁc
manner rather than uniformly impairing the entire Akt signalling
network.
Dysregulated substrate phosphorylation was even more
pronounced for mTOR and AMPK (Fig. 3b, c), where we
observed examples of substrate phosphorylation being inhibited
or enhanced by oxidative stress. Since both kinases are regulated
by Akt, these changes may in part reﬂect the reduced Akt activity
under these conditions. However, both kinases were reversibly
oxidized in the presence of BCNU/AF (mTOR on C713; AMPK
on C205 on the gamma subunit), supporting the concept that
cysteine oxidation of these kinases may alter activity toward
speciﬁc substrates.
Collectively, oxidative stress has a complex effect on kinase-
substrate relationships and a loss of signal ﬁdelity, as indicated by
the increase in variability in substrate phosphorylation, is one of
the most consistent outcomes of oxidative stress.
Identiﬁcation of oxidative modiﬁcations on Akt. Our multi-
omics analyses uncovered discordance between Akt phosphor-
ylation at its activation site T309 and downstream substrate
phosphorylation following acute oxidative stress. Given that we
identiﬁed oxidation of C77 under the same conditions, we
hypothesised that the direct oxidation of Akt itself could, at least
in part, explain these observations. To explore this, we developed
a non-reducing immunoprecipitation-mass spectrometry (IP-
MS) assay to identify speciﬁc oxidative modiﬁcations of Akt
(Supplementary Fig. 4a and b). Two disulﬁde bonds were iden-
tiﬁed in Akt2: C60-C77 within the PH domain (Supplementary
Fig. 4c) and C297-C311 within the kinase domain (Supplemen-
tary Fig. 4d). We also observed two S-glutathionylation sites at
C124 and C311 (Supplementary Fig. 4e and f). Importantly, these
were exclusively identiﬁed in samples treated with BCNU/AF for
2 h, implying that the majority of Akt exists without oxidative
modiﬁcations in the normal cellular redox environment. Both
disulﬁdes have been reported previously41–43. The disulﬁde
between C297-C311 (the T-loop disulﬁde) has been implicated in
kinase inhibition, possibly in combination with the oxidation of
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C12441,42,44,45. Whilst the functional consequence of the PH
domain disulﬁde (C60-C77) has not been explored, it has been
identiﬁed as a cross-strand disulﬁde, consistent with it acting as a
disulﬁde switch that may regulate PIP3 binding46.
C60 and C77 are required for Akt activation. The PH domain is
essential for Akt recruitment to the PM and its phosphorylation at
T309 and S47447,48. Since oxidative stress induced hyper-
phosphorylation of Akt-T309, we hypothesized that the PH
domain disulﬁde may promote Akt recruitment to the PM. To
explore this and to avoid the confounding issue of endogenous
Akt activity, we utilised the Akt-W80A MK2206-resistant
system49,50. Treatment of cells with the Akt inhibitor MK2206
inhibited both endogenous Akt and overexpressed Akt2-WT
activation as demonstrated by impaired phosphorylation of Akt at
T309 and its substrates TSC2 and PRAS40 (Fig. 4a, b). Since the
W80A mutation prevents binding of MK-2206 to Akt49,50,
insulin-stimulated activation of Akt2-W80A was not impaired by
MK-2206 (Fig. 4a, b). Under these conditions, phosphorylation of
Akt2-C60/77S-W80A at T309 and S474 and Akt substrates TSC2
and PRAS40 were impaired by approximately 70% (Fig. 4a, b).
Consistent with these observations, DNA content, cell growth
and colony formation were lower in cells expressing Akt2-C60/
77S-W80A compared to cells expressing Akt2-W80A (Fig. 4c–h)
This implies that either C60, C77 or both Cys residues are
necessary for insulin-stimulated Akt activation even in the
absence of oxidative stress.
C60 and C77 of Akt are essential for Akt activation in vivo. To
address whether C60 and C77 played a similar role in vivo we
utilised the Gal4-UAS system51 to overexpress human Akt2-WT
(hAkt2-WT) or the Akt2-C60/77S mutant (hAkt2-C60/77S) in
Drosophila melanogaster. We did not observe any gross
abnormality between hAkt2-WT and hAkt2-C60/77S over-
expressing ﬂies, suggesting that endogenous dAkt1 function is
sufﬁcient to sustain normal growth and development. Overnight
starvation followed by the administration of 10% glucose for 30
or 60 min increased phosphorylation of S505 on Drosophila Akt1
(dAkt1; Fig. 4i). Under the same conditions, hAkt2-WT, but not
hAkt2-C60/77 S, displayed feeding-induced phosphorylation at
T309 and S474, indicating that mutation of C60 and C77
inhibited Akt activation in vivo (Fig. 4i).
To determine if C60 and C77 of hAkt2 were functionally
relevant in vivo we knocked down dAkt1, while overexpressing
either hAkt2-WT or hAkt2-C60/77S. No live adults emerged with
whole body knockdown of dAkt1, consistent with previous
observations of early lethality52. In contrast, depletion of dAkt1
and expression of hAkt2-WT resulted in live adults (Fig. 4j). Flies
expressing hAkt2-C60/77 S, were signiﬁcantly smaller (Fig. 4j),
and displayed decreased body weight, body length and wing size
(Fig. 4k–m). hAkt2-WT, but not hAkt2-C60/77S, could be fully
activated by refeeding, as determined by phosphorylation at T309
and S474 (Fig. 4n). Intriguingly, hAkt2-C60/77S was constitu-
tively phosphorylated at T309, but S474 phosphorylation was
impaired (Fig. 4n). Taken together, these data suggest C60 and
C77 are required for Akt activation in vivo.
MD analysis suggests C60 and C77 regulate PIP3 binding. To
gain mechanistic insight into the role of the PH domain disulﬁde,
we performed molecular dynamics (MD) simulations using the
PH domain of Akt with either the C60-C77 disulﬁde intact or
where the two cysteine residues were substituted with serines. We
focused this analysis on the 3 loops involved in phosphatidyli-
nositol(3,4,5)-trisphosphate (PIP3) binding: loop 1 (residues
7–31), loop 2 (residues 52–66) and loop 3 (residues 72–90)
(Fig. 5a). Comparison of the snapshots at 100 ns with the refer-
ence crystal structure (PDB:1unp) revealed a conformational
change at the tip of loop 1 (E17–Y18) in Akt-C60/77S but not in
wild type (WT) Akt (Fig. 5b, c). Examination of the ionic bond
between E17 and R86 revealed it was maintained in WT Akt but
it was broken in Akt-C60/77S (Fig. 5d). The Cα–Cα distances
between the same residues also increased in Akt-C60/77S
(Fig. 5e), showing that this was not just due to the motion of the
side chains but also involved loop 1 moving away from loop 3.
Comparison of the RMSDs of loops 1, 2 and 3 between the WT
and mutant Akt showed that breaking the disulﬁde bond had a
large effect on the conformation of loop 1 but not on loops 2 and
3, which are connected by the disulﬁde bond (Fig. 5f–h). For
more detailed information, we examined the residue-speciﬁc
RMSDs in loop 1 (Fig. 5i), which revealed that the largest changes
between WT Akt and Akt-C60/77S occurred around the E17
residue. For control purposes, we also performed MD simulations
of Akt with protonated C60/77, which breaks the disulﬁde bond
without affecting the side chains. Comparison of the residue-
speciﬁc RMSDs in loop 1 with those of Akt-C60/77S showed
similarly increased ﬂuctuations in the vicinity of E17 (Fig. 5i,
Supplementary Fig. 5. a–e), indicating that breaking of the dis-
ulﬁde bond is responsible for the changes in loop 1.
Since loop 1 residues contribute seven contacts to binding of
PIP3 (loop 2 and 3 residues contribute only one contact each;
Supplementary Table 1), the opening of the PIP3 binding pocket in
the C60/77S mutant may impair its ability to bind PIP3. To test this,
we docked PIP3 to WT Akt and Akt-C60/77S. The nine contacts
obtained from docking of PIP3 to WT Akt were maintained during
the MD simulations (Supplementary Table 1). In contrast, only
three residues of Akt-C60/77S (K14, R25 and N53) were involved in
docking of PIP3, which were rapidly broken in subsequent MD
simulations (Fig. 5j–l) indicating that PIP3 binds less stably to Akt-
C60/77S than WT Akt with the disulﬁde bond.
C60 and C77 regulate PIP3 binding and Akt recruitment.
Consistent with our MD predictions, direct oxidation of the Akt
PH domain with H2O2 increased its binding afﬁnity for PIP3
(Fig. 6a, b). Total internal reﬂection ﬂuorescence (TIRF) micro-
scopy53 of TagRFPt-Akt2-WT or TagRFPt-Akt2-C60/77S in live
adipocytes revealed that insulin-stimulated translocation of the
Akt2-C60/77S mutant to the cell surface was not detectable in the
presence of either 1 or 100 nM insulin in contrast to Akt2-WT
(Fig. 6c). This suggests that the impaired insulin-stimulated
activation of Akt2-C60/77S (Fig. 4a) is due to impaired PM
recruitment. Taken with the MD simulation, these data lead us to
predict that: (1) the C60-C77 disulﬁde promotes Akt afﬁnity for
PIP3; (2) increased formation of the C60-C77 disulﬁde would
promote Akt PM accumulation; and (3) that deletion of either
cysteine residue would ablate these effects. If the disulﬁde bond in
the PH domain of Akt is essential for recruitment, we would
expect the single cysteine mutants to phenotypically mimic the
response of the Akt2-C60/77S double mutant.
We measured insulin-stimulated PM translocation of Akt2-
C60S and Akt2-C77S. Intriguingly, these mutants exhibited
markedly different responses to insulin. Whilst the C77S mutant
phenocopied the complete loss of recruitment observed for the
C60/C77S mutant, the C60S mutant displayed an intermediate
phenotype (Fig. 6c). Consistent with this, insulin stimulated
phosphorylation of Akt2-C60S at T308 was ﬁve-fold lower than
Akt WT and not detectable for either the C77S or C60/77S
mutants (Fig. 6d, e).
These data suggest that both cysteines are necessary for normal
insulin-stimulated Akt recruitment and that C77 plays a more
signiﬁcant role in insulin-stimulated Akt translocation than C60.
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Cancer mutation C77F functionally mimics oxidized PH
domain. The importance of C77 is reinforced by the activating
breast cancer-associated Akt1-C77F mutation54,55. Indeed,
both full length and PH domain Akt1-C77F mutants were
hyper-responsive to insulin when compared to the WT controls
(Fig. 6f, g), suggesting that the Akt1-C77F mutation may func-
tionally mimic oxidative modiﬁcation and increase PIP3 binding.
MD simulations on the PH domain of Akt were performed to
investigate how the C77F mutation could increase PIP3 afﬁnity.
Examination of the critical E17-R86 ionic bond revealed that
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following a period of equilibration (~60 ns), the distance between
the residues decreased and a highly stable state was achieved
(Fig. 6h; Supplementary Fig. 5f–i). In WT Akt, E17 interacts with
both K14 and R86, which is responsible for the ﬂuctuations in the
E17-R86 distance. The small conformational change caused by
the C77F mutation brings loop 1 nearer to loop 3, enabling
simultaneous contact of E17 with K14 and R86. This increased
stability coincided with the formation of a hydrophobic pocket
involving interactions between F77, F55, I75 and I84 (Fig. 6i, k).
The residue-speciﬁc RMSDs in loop 1 were found to be similar to
that of WT Akt (Fig. 5f). Thus, this hydrophobic interaction was
as effective as the disulﬁde bond in stabilizing the PIP3 binding
pocket. Indeed, when PIP3 was docked to Akt-C77F, a similar
binding mode to that of WT Akt was obtained with nine contacts
involving the same Akt residues (Supplementary Table 1). These
contacts were maintained during the MD simulations as indicated
by the average distances obtained from MD consistent with
increased binding afﬁnity when compared to C60/C77S and
reduced WT Akt. This suggests that C77F functionally mimics
oxidized Akt containing the C60-C77 disulﬁde, resulting in
hyperactive Akt signalling.
A role for the C60-C77 disulﬁde in growth factor signalling.
The above data are consistent with C60/C77 oxidation increasing
PIP3 binding. Indeed, treatment of cells with BCNU/AF or H2O2
(through the addition of H2O2 directly, or produced by glucose
oxidase in the medium) to oxidize Akt, increased insulin-
stimulated PM recruitment of Akt (Fig. 7a, b).
Given that insulin has been reported to increase ROS56–58, we
propose a redox-dependent mechanism that promotes Akt
translocation to the PM in response to growth factors, where
growth factor-induced ROS, likely a product of NADPH oxidase
4 (NOX4) in adipocytes, oxidizes C60–C77 and enhances the Akt
response to insulin-stimulated PIP3 production.
To explore this, we created a simpliﬁed mechanistic model of
Akt signalling (Fig. 7c) and trained it with Akt PM recruitment
(Fig. 7a) and Akt/Akt substrate phosphorylation data (Supple-
mentary Fig. 6a, b) in the absence or presence of BCNU/AF
(Detailed model description is given in the Supplementary Note 1
and Supplementary Tables 3, 4 and 5). The trained model
quantitatively recapitulated the experimental data, lending
support to the proposed mechanism (Fig. 7d). Next we examined
how BCNU/AF would inﬂuence Akt binding to PIP3. Addition-
ally, the model predicted enhanced PH domain PIP3 binding
kinetics in the presence of BCNU/AF (Fig.7e), in close agreement
with our observations of the puriﬁed PH domain binding to PIP3
(Fig. 6a, b). We then predicted the effect of NOX inhibition on
insulin-stimulated Akt recruitment (Fig. 7f) and increasing
concentrations of a NOX inhibitor (diphenylene iodinium, DPI)
on the phosphorylation of Akt and its substrates (Fig. 7g). To test
the accuracy of the predicted response, we treated adipocytes with
DPI prior to insulin stimulation. DPI impaired Akt PM
recruitment at both 1 and 100 nM insulin (Fig. 7h). We also
observed dose-dependent inhibition of Akt phosphorylation at
T309, S473 and Akt substrate phosphorylation (PRAS40 T246
and Foxo1/3a T24/32) (Fig. 7i; Supplementary Fig. 6e–f). Despite
the fact that DPI is known to bind to additional targets other than
NOX459,60, these data are consistent with the model prediction
(Fig. 7f).
This model assumes that insulin will increase formation of the
PH domain disulﬁde, via the ROS burst. This was directly
assessed in ﬂag tagged Akt1 overexpressed in NIH/3T3 cells over
a time course of insulin stimulation using differential cysteine
labelling (Fig. 7j). Oxidation of C60 was observed in approxi-
mately 0.5% of the total Akt1 pool between 0 and 5 min of insulin
stimulation (Fig. 7k), consistent with the highly reducing
environment of the cytosol. The proportion of Akt that was
oxidized at C60 increased 2.5-fold with longer term insulin
stimulation (Fig. 7k; 10–60 min). The redox state of Cys297 of the
kinase domain was unchanged with insulin stimulation (Fig. 7k).
These data support the formation of the C60-C77 disulphide in
Akt and that it is regulated by insulin under physiological
conditions.
Discussion
Protein oxidation is an efﬁcient modulator of protein function
under physiological and pathophysiological conditions. Here we
combine a model of oxidative stress with a multi-omics approach
to explore the interaction between ROS-dependent protein oxi-
dation and phospho-signalling. ROS has a profound inﬂuence on
the adipocyte phosphorylation signalling network principally by
inﬂuencing the ﬁdelity of signalling at key regulatory nodes
including Akt, mTOR and AMPK. In particular, we identify a
number of oxidative modiﬁcations including two disulﬁde bonds
that form in Akt and provide evidence that oxidation of C60 and/
or C77, or the formation of a disulﬁde bond between these
residues, stabilises the PIP3 binding pocket and promotes Akt
activation through PM recruitment. Deletion of both C60 and
C77 impairs Akt activity and results in cellular and whole-body
phenotypes consistent with Akt hypoactivity.
Analysis of the redox proteome in combination with the
phosphoproteome revealed a major effect of oxidative stress on
signal transduction. To avoid the difﬁculties in interpreting
unannotated and potentially promiscuous protein phosphoryla-
tion sites61,62, we focused on three ROS-regulated kinases: Akt,
mTOR and AMPK. Examination of kinase-substrate relationships
in these subnetworks revealed varied effects of oxidation on dif-
ferent substrates (Fig. 3b, c). For example, only 11 out of 36 Akt
substrates were modulated by treatment with BCNU/AF and the
same was true for AMPK and mTOR, with these kinases
Fig. 4 C60 and C77 of Akt are essential for Akt activation in vitro and in vivo. a Representative immunoblots of Akt activation and signalling. 3T3-L1
ﬁbroblasts overexpressing Akt2 -WT, -W80A or -W80A-C60/77S were serum starved and then treated with MK-2206 (10 μM, 30min) prior to
stimulation with insulin. b Quantiﬁcation of Akt activation and signalling blots. Data are mean ± SEM from n= 3, (***p < 0.001, ****p < 0.0001) by two-way
ANOVA. c Expression level of Akt mutants in HeLa cells transfected with indicated vectors for 24 h. d Proliferation of HeLa cell overexpressing Akt2-WT or
indicated mutants measured by Hoechst. Data are mean ± SEM from n= 4, **p < 0.01 by one-way ANOVA. e Colony formation assays were performed
using HeLa cells overexpressing corresponding Akt2-WT or indicated mutants. Colony numbers were counted and shown as mean ± SEM from n= 8, *p <
0.05 by Brown-Forsythe and Welch ANOVA tests. f Representative images of soft HeLa colonies. g Anchorage-independent cell growth was assessed by
soft agar assays using HEK cells overexpressing Akt2-WT or indicated mutants. Colony numbers were counted and shown as mean ± SEM from n= 6, *p <
0.05 by one-way ANOVA. h Representative images of HEK colonies. i Flies overexpressing hAkt2-WT or hAkt2-C60/77S were starved overnight and re-
fed for 30 or 60min. Flies were sacriﬁced and the samples were immunoblotted using indicated antibodies. j Representative images of ﬂies with depletion
of dAkt1 and simultaneous overexpression of human hAkt2-WT or hAkt2-C60/77S. k–m Fly growth were determined by the measurement of body weight
(k), body length (l) and wing size (m); ***p < 0.001 by Welch’s t-test. n Flies with depletion of dAkt1 and overexpression of hAkt2-WT or hAkt2-C60/77S
were starved overnight and re-fed for 30 or 60min. Flies were sacriﬁced and the samples were immunoblotted using indicated antibodies.
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Fig. 5MD simulations predict the C60-C77 disulﬁde in Akt increases PIP3 afﬁnity. a Akt1 PH domain (1unp) showing the disulﬁde bond between C60 and C77,
the key residues required for PIP3 binding and loops 1 to 3. b Comparison of the Akt1 crystal structure 1unp (transparent) with the WT and c C60/C77S
structures obtained after ~100 ns MD. d Time series of the E17(O)-R86(N) distance in WT and mutant Akt1. Only the distance between the closest O-N atoms
are shown. e Time series of the Ca-Ca distances between the residues E17 in loop 1, and R86 in loop 3 in WT and mutant Akt1. f–h Comparison of the backbone
RMSDs of the three loops in WT and mutant Akt1 calculated using the crystal structure as a reference. For loop 1, the RMSD is calculated for the residues
12–26, which are involved in binding of PIP3. i Residue speciﬁc RMSDs of the loop 1 residues 12–26 for the WT and C60/77S and protonated C60/77 mutant
Akts. j–l Time series of the contact distances involved in PIP3 binding to WT Akt (blue) and Akt-C60/77/S (red). jWT Akt K14(NZ)–PIP3 (OPG/H) and Akt-
C60/77S K14(NZ)–PIP3 (OPH). kWT Akt R25(N2)–PIP3 (O5P/O6P) and Akt-C60/77S R25(N2)–PIP3 (OPG). lWT Akt N53(ND2)–PIP3 (O6P/O8P) and Akt-
C60/77S K14(ND2)–PIP3 (O8P). m Snapshots of WT (left-hand panels) and mutant (right-hand panels) Akt1-PIP3 complex at 0 and 50 ns.
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exhibiting both decreased and increased substrate phosphoryla-
tion. This suggests that oxidative stress impairs signal ﬁdelity
rather than kinase activity. This is perhaps not surprising because
redox-dependent modiﬁcations of many intermediates in signal-
ling pathways can have diverse functional outcomes such as
alterations in activity, localisation or substrate speciﬁcity. In
addition, oxidation of substrates may alter their localisation/
binding partners and/or their cognate phosphatase activity, fur-
ther exacerbating signal dysregulation. As such, the effect of
oxidative stress on the global phosphoproteome will represent the
integrated output of all of these inﬂuences. Therefore, we propose
that oxidative stress will induce greater variability in the phos-
phorylation of substrates for kinases with a greater number of
regulatory inputs. Consistent with this idea, substrate dysregula-
tion was most marked for mTOR, which is downstream of
multiple regulatory inputs including Akt.
Detailed analysis of Akt revealed how the integrated effect of
different oxidative modiﬁcations within the one kinase can deﬁne
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signalling outcomes. Akt is hyper-phosphorylated at its activating
site T309 under oxidative stress and yet its activity appears
impaired (Fig. 3b, Supplementary Fig. 3c and Supplementary
Fig. 6a). We propose that Akt hyper-phosphorylation is driven (at
least in part) by increased Akt PM recruitment that is supported
by oxidation of C60–C77, while Akt kinase activity is attenuated
by oxidation of C297–C311 perhaps in combination with glu-
tathionylation of C124, as has been described previously41,42,44,45.
We note that BCNU/AF also increased both PM localization and
Akt T308 phosphorylation in the absence of insulin. The mag-
nitude of the basal T308 increase combined with the modest
increase in PM localised Akt, leads us to speculate that additional
mechanisms may be involved in the hyperphosphorylation. For
example the C297–C311 disulﬁde may protect T308 from phos-
phatases or the T308 phosphatase itself (PP2B) may be impaired
by ROS as ROS has been shown to impair Ser/Thr phosphatase
activity63.
The PH domain disulﬁde (C60–C77), ﬁrst identiﬁed in crystal
structures43, is a cross strand disulﬁde (CSD) that has been
conserved since its appearance prior to the triplication of Akt46. It
has the archetypal –RH staple allosteric conﬁguration, suggesting
that it is redox active46,64,65. Mutational analysis of Akt C60 and
C77 implies that these residues are required for the PIP3-
dependent recruitment of Akt to the PM and this is supported by
MD simulations that suggest that the presence of the disulﬁde
bond between these residues stabilises the PIP3 binding pocket.
Our data suggest that C77 may play a more central role in Akt
activation than C60. One possibility is that C77 oxidation alone,
without formation of a disulﬁde bond with C60, can regulate Akt
activation to some extent. The critical role of this residue in Akt
activation is exempliﬁed by the oncogenic mutation C77F, which
increases Akt activity due to increased afﬁnity for PIP3.
Mechanistically this occurs via the formation of strong hydro-
phobic interactions between F77 and the hydrophobic pocket
(F55, I75 and I84), that stabilises PIP3 binding. Unlike the dis-
ulﬁde bond, this interaction is not reversible and results in
hyperactive Akt. Although we utilised a model of oxidative stress
to initially identify the C60–C77 disulﬁde bond in Akt, we also
demonstrate increased C60–C77 bond abundance following
insulin-stimulation (Fig. 7k), suggesting that this site is sensitive
physiological ROS. Therefore, we propose a redox-dependent
mechanism for promoting Akt translocation to the PM in
response to growth factors (Fig. 8). Previous studies have
demonstrated that growth factors, such as insulin, stimulate a
localised burst of ROS (likely at the PM) that is essential for signal
transduction56–58. Our data suggest a model where insulin
increases the disulﬁde between C60–C77, increasing the afﬁnity
of Akt for PIP3 and promoting Akt activation. We note that
under severe oxidative stress, accumulation of Akt at the PM may
be exacerbated by the suppression of PTEN activity, resulting in
increased PIP36. Whilst our analysis has focused on the PH
domain, it has been proposed that the PH domain auto-inhibits
the kinase domain, which is relieved when the PH domain binds
membrane lipid66. Thus it is possible that the redox state of the
PH domain cysteines may also regulate the PH domain:kinase
domain interaction.
We have recently shown that Akt is ﬁrst phosphorylated at
T309 leading to partial activation of the kinase67. Akt then
phosphorylates and activates the mTORC2 complex in a positive
feedback loop that facilitates phosphorylation of Akt at S474 to
fully activate the kinase50,68. We observed uncoupling of Akt
T309 and S474 phosphorylation in BCNU/AF-treated cells
(Supplementary Data 7), likely due to the formation of an inhi-
bitory disulﬁde bond (C297–C311) in the kinase domain. This
would impair mTORC2 activation and decrease S474 phos-
phorylation. Indeed it has been demonstrated that loss of the
hydrophobic motif phosphorylation site in Drosophila, by either
mutation or truncation, has no effect on ﬂy growth, whilst loss of
TORC2 activity results in impaired PIP3/Akt-dependent hyper-
plasia69. Thus, the observed growth phenotype in our Drosophila
experiments is likely a result of lower TORC2 activity, down-
stream of impaired Akt activation.
Our multi-omics approach has produced a comprehensive atlas
integrating global quantitative changes to the redox proteome,
phosphoproteome and proteome of adipocytes that serves as a
resource for research into the interaction between redox and
phospho-signalling. Our analysis reveals widespread and complex
crosstalk between these pathways that culminates in a loss of
signal ﬁdelity, and highlights a regulatory mechanism on Akt.
Methods
Antibodies used in this study. anti-PRDX2 (Abcam, ab71533); anti-PRDX3
(Abfrontier, BS-1874R); anti-AKT-pT309 (CST, 9275); anti-AKT-pS474 (CST,
4051); anti-AKT2 (CST, 3063); anti-AS160-pT642 (CST, 4288); anti-TSC2-pT1462
(CST, 3611); anti-PRAS40-pT247 (CST, 2997); anti-GSK3a-pS21 (CST, 9327);
anti-IRS1-pS307 (CST, 2381); anti-FOXO1-pT256 (CST, 9461); anti-mTOR-
pS2448 (CST, 5336); anti-p70S6K-pT390 (CST, 9234); anti-p70S6K-pT421/S424
(CST, 9204); anti-RICTOR-pT1135 (CST, 3806); anti-S6-pS240/S244 (CST, 2215);
anti-AMPKa-pT183 (CST, 2535); anti-ACC-pS79 (CST, 3661); anti-dAKT-pS505
(CST, 4054); anti-Tubulin (CST, 5335); anti-Tubulin (CST, 5335); anti-Actin (CST,
4967); anti-RFP (Life technologies, R10367); anti-FLAG (Sigma, F3165); anti-14-3-
3 (Santa Cruz, sc-1657); all the other antibodies are home made.
Cell culture and treatments. 3T3-L1 ﬁbroblasts (a gift from Howard Green,
Harvard Medical School) were grown in Dulbecco’s modiﬁed Eagle’s medium
(DMEM) containing 10% fetal bovine serum (FBS, Hyclone Laboratories) and
2 mM GlutaMAX (Gibco) in 10% CO2 at 37 °C. For differentiation into adipocytes,
cells were grown to conﬂuence, then treated with DMEM/FBS containing 4 µg/ml
insulin, 0.25 mM dexamethasone, 0.5 mM 3-isobutyl-1-methylxanthine and
100 ng/ml d-biotin. After 72 h, the differentiation medium was replaced with fresh
FCS/DMEM containing 4 µg/ml insulin and 100 ng/ml d-biotin for a further
3 days, then replaced with fresh FCS/DMEM. Adipocytes were re-fed with FCS/
DMEM every 48 h and utilized for experiments between 9 and 12 days after the
initiation of differentiation. These cells were routinely tested for mycoplasma.
Fig. 6 C60 and C77 are required for Akt activation. a In vitro protein-lipid overlay assay. Aliquots of puriﬁed Akt2 PH domain (N-terminal 111 residues) was
reduced or oxidized by DTT or H2O2, respectively, and then incubated with membranes spotted with serial dilutions of PIP3. Binding afﬁnity was assessed
by immunoblotting. b Quantiﬁcation of in vitro protein-lipid overlay assay. Data are shown as mean ± SEM from n= 3. For oxidized Akt2 PH domain,
Hillslope= 2.407, EC50= 28.84; for reduced Akt2 PH domain, Hillslope= 1.908, EC50= 52.30. p-value from two-way ANOVA. c Assessment of Akt
translocation to the PM by TIRF. Adipocytes overexpressing TagRFPt-Akt2-WT or TagRFPt-Akt2-C60/77S were serum starved, followed by insulin
treatments (1 nM and 100 nM). Data are shown as mean ± SEM. d Representative immunoblots of Akt2 phosphorylation at T309. 3T3-L1 ﬁbroblasts
overexpressing TagRFPt tagged Akt2 -WT, C60S, C77S or C60/77S were serum starved and then treated with MK-2206 (10 μM, 30min) prior to
stimulation with insulin. e Quantiﬁcation of T309 phosphorylation. Data is mean ± SEM from n= 3. f Translocation of tagRFPt tagged Akt1 WT, C77F or
C60/C77S to the plasma membrane in response to 1 nM or 100 nM insulin, measured by TIRFm. g, f Translocation of tagRFPt tagged Akt1 WT, C77F or
C60/C77S PH domains to the plasma membrane in response to 1 nM or 100 nM insulin, measured by TIRFm. h Time series of the E17(O)-R86(N) distance
in Akt1-C77F. Only the distance between the closest O–N atoms are shown. i Time series of the F55(CZ)-F77(CD1) distance in the C77F mutant Akt1.
Equilibrium conﬁguration is reached after 60 ns. j C77F hydrophobic interactions. The F77 side chain strongly interacts with the F55, I75 and I84 residues
which form a hydrophobic pocket. k Residue speciﬁc RMSDs of the loop 1 residues 12-26 for the WT and C60/77S and protonated C60/77 mutant Akts.
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Fig. 7 A physiological role for C60 and C77. a, b TIRF imaging of adipocytes overexpressing TagRFPt-Akt2-WT treated with a BCNU/AF or H2O2 (100 µM)
or b glucose oxidase (GOD) as indicated prior to stimulation with 1 nM insulin. Data are mean ± SEM. c The simpliﬁed mechanistic AKT oxidation-
phosphorylation network model. Ins Insulin, IR Insulin receptor, NOX NADPH oxidase 4, DPI diphenylene iodinium, ROS reactive oxygen species, Akt-ox
oxidized Akt, Akt-red reduced Akt, Akt-ox-PM oxidized PM Akt, Akt-red-PM reduced PM Akt. Reaction numbers rx (x= 0–37) denote the model reactions
(Supplementary Tables 1 and 2). d Simulated response of Akt-PM and phospho-Akt levels with either insulin stimulation alone, or in combination with
BCNU/AF, using a representative best-ﬁtted model parameter set. e Model prediction of the inﬂuence of BCNU/AF on Akt recruitment in response to
increasing amounts of PIP3. Predictions are averaged using three independent best-ﬁtted parameter sets (Supplementary Table 2); Data are mean ± SEM.
fModel prediction of the effect of DPI on Akt recruitment under a low (at 0min time-point) or high level (at 10 min time-point) of insulin stimulation. Data
are mean ± SEM. g Model prediction of the effect of increasing DPI concentration on Akt (left panel) and Akt substrate phosphorylation (right panel). DPI
was added for 30min prior to a 10min insulin stimulus. h, i Experimental validation of model predictions. h Adipocytes overexpressing TagRFP-T-Akt2-WT
were imaged by TIRFm and treated with either DMSO or 10 μM DPI 10 min prior to insulin stimulation. i DPI dose response. Adipocytes were pretreated
with the indicated dose of DPI for 30min prior to stimulation with 1 nM insulin. j Differential cysteine alkylation and mass spectrometry method of
measuring the redox state of Akt1 cysteines. Unpaired cysteine thiols were alkylated with 12C-IPA and the oxidized thiols with 13C-IPA following reduction
with DTT. k Box (inter-quartile range; median) and whiskers (min:max) plots showing the oxidation of Cys60 and Cys297 in NIH/3T3 ﬁbroblasts in the
presence or absence of 10 nM insulin. Peptide were binned into 0–5min and 10–60min insulin periods. Two biological replicates were performed. *p < 0.05
by two-sided Wilcoxon rank sum test.
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For total proteomic analysis, 3T3-L1 ﬁbroblasts were triple SILAC labelled70.
All studies used adipocytes between 8 and 12 days after differentiation. Cells were
treated with 100 μM BCNU or 1 μM AF for the indicated times.
L6 rat myoblasts (ATCC® CRL-1458™) were grown in α-Minimum essential
medium (α-MEM) containing 10% FBS (Hyclone Laboratories) in 10% CO2 at
37 °C. L6 myoblasts were differentiated into myotubes using α-MEM with 2% FBS
when myoblasts reached 90–95% conﬂuence. All L6 studies used myotubes
between 6 and 8 days after differentiation.
Plasmid transfection. HEK293 (ATCC® CRL-1573™) or HeLa (ATCC® CCL-2™)
cells were cultured in DMEM containing 10% FBS and 2mM GlutaMAX in 10%
CO2 at 37 °C, which were transfected at approximately 80% conﬂuency using
Lipofectamine 2000 (Life Technologies) according to the manufacturer’s instructions.
Sample preparation and mass spectrometry of redox proteome. Adipocytes
were incubated with ice-cold PBS containing 10% TCA for 1 min on ice, and
washed once. Cells were then harvested in buffer containing 50 mM HEPES, 1 mM
EDTA, 0.1% SDS and 10% TCA. Proteins were precipitated at 4 °C for 2 h. Samples
were then centrifuged at 16,000 × g for 20 min at 4 °C, and the pellets were washed
once using pre-chilled acetone. Protein pellets were resuspended in buffer con-
taining 6 M Urea, 50 mM HEPES (pH 8.5) and alkylated with 100 mM IAA at
room temperature for 40 min in the dark. Excess IAA was removed by using 30 k
ﬁlters and proteins were re-suspend in HES buffer (50 mM HEPES, 1 mM EDTA,
0.1% SDS, pH 8.0). Protein concentrations were determined by BCA protein assay
and adjusted to 1 μg/μL. To each 100 μg sample, 5 mM TCEP was used for reducing
at 50 °C for 1 h, and then iodoTMT quantitative tags were added and incubated at
37 °C for another 1 h in darkness. After adding 20 mM DTT to quench the reac-
tion, equal amounts of each labelled sample were combined and precipitated using
pre-chilled acetone overnight. Protein pellets were resuspended in buffer con-
taining 6 M urea, 2 M thiourea, 25 mM TEAB, and protein mixture was digested
using LysC (enzyme:substrate 1:100) at 30 °C for 2 h. The protein solution was then
diluted 1:5 using 25 mM TEAB and further digested with trypsin (enzyme:substrate
1:50) at 37 °C overnight. The peptide mixture was desalted using stage-tips and
separated by HILIC system for mass spectrometry analysis. Four replicates were
performed including two forward labelling and two reverse labelling strategies. For
the forward labelling, tag-126, -127, -128, -129, -130 and -131 were used to label
the samples Ctrl1, BCNU 2 h, BCNU 24 h, Ctrl2, BCNU/AF 2 h and BCNU/AF
24 h, respectively. For the reverse labelling, tag-126, -127, -128, -129, -130 and -131
were used to label BCNU/AF 24 h, BCNU/AF 2 h, Ctrl2, BCNU 24 h, BCNU 2 h
and Ctrl1, respectively.
MS-based redox proteomic analysis was performed on an Easy nLC-1000
UHPLC coupled to a Q Exactive mass spectrometer in positive polarity mode.
Peptides were separated using an in-house packed 75 μm× 40 cm column (1.9 μm
particle size, ReproSil Pur C18-AQ) with a gradient of 5–30% ACN containing
0.1% FA over 90 min at 200 nL/min at 55 °C. The MS1 scan was acquired from
300 to 1750m/z (70,000 resolution, 3e6 AGC, 100 ms injection time) followed by
MS/MS data-dependent acquisition of the top 20 ions with HCD (17,500
resolution, 5e5 AGC, 60 ms injection time, 30 NCE, 2.0m/z isolation width).
Raw data was processed using MaxQuant (v1.6.1.2)71 against a UniProt mouse
database (06/2017, 59,581 entries) with default settings and minor changes:
Oxidation of methionine and acetylation of protein N-terminus were set as variable
modiﬁcations. IodoTMT6-plex of isobaric labels was enabled and reporter mass
tolerance was set to 0.01 Da. Second peptides search was enabled. Peptide match
tolerance was set to 20 ppm and 4.5 pm for ﬁrst and main searches respectively and
MS/MS match tolerance set to 20 ppm. Both peptide spectral match (PSM) and
protein FDR were set to 1%. This led to the identiﬁcation of 281,345 unmodiﬁed
and 66,002 iodoTMT-modiﬁed PSMs.
Sample preparation and mass spectrometry of phosphoproteome. Samples
selected for MS analysis were processed using the recently described EasyPhos
workﬂow35. Brieﬂy, cells were washed three times with TBS, scraped in SDC
lysis buffer (4% (w/v) SDC, 100 mM Tris HCl, pH 8.5) and boiled immediately
(95 °C, 5 min). Lysates were cooled on ice, sonicated (2 × 30 s), and centrifuged at
20,000 × g for 15 min at 4 °C until a layer of fat formed. Clariﬁed protein was
carefully collected without disturbing the upper fat layer, and protein concentration
was determined by BCA assay. Four hundred micrograms of protein was reduced
and alkylated in a single step using TCEP and 2-Chloroacetamide respectively, and
protein was digested in a 96-well plate by the addition of Trypsin and LysC (1:100
enzyme-protein ratio) overnight at 37 °C. Phosphopeptides were enriched in par-
allel format using the EasyPhos workﬂow as described36. To the digested peptides
in 300 μl of SDC buffer (4% sodium deoxycholate, 100 mM Tris pH 8.5) in a 2 mL
Deep Well Plate, 400 μl isopropanol was added and samples mixed (30 sec, 1,500
rpm). 100 μl enrichment buffer (48% TFA, 8 mM KH2PO4) was added and samples
mixed (30 sec, 1,500 rpm). TiO2 beads were subsequently added to the peptides at a
ratio of 12:1 beads/protein (suspended in 80% acetonitrile, 6% TFA) and incubated
at 40 °C for 5 min at 2000 r.p.m. Beads were subsequently pelleted by centrifuga-
tion (2000 × g, 1 min) and the supernatant (containing non-phosphopeptides) was
aspirated and discarded. Beads were re-suspended in Wash buffer (60% iso-
propanol, 5% TFA) with mixing (2000 rpm, 30 s), then pelleted (2000 × g, 1 min)
and the supernatant discarded. Beads were washed a further four additional times
with 1 ml wash buffer. After the ﬁnal wash, beads were re-suspended in 100 μl
transfer buffer (60% ACN, 0.1% TFA) and transferred onto the top of a C8
StageTip, and centrifuged for 3–5 min at 500 × g until no liquid remained on
StageTip. Bound phosphopeptides were eluted 2× with 30 μl Elution buffer (40%
ACN, 20% NH4OH (25%, HPLC grade)), and collected by centrifugation into
clean PCR tubes. Samples were concentrated in a SpeedVac for 30 min at 45 °C
then immediately acidiﬁed by the addition of 99% isopropanol/1% TFA, and
loaded directly onto the top of an SDB-RPS StageTip. After loading StageTips were
washed once with SDB-RPS Wash buffer 1 (99% isopropanol/1% TFA) and once
with SDB-RPS Wash buffer 2 (0.2% TFA, 5% acetonitrile), then phosphopeptides
were eluted from StageTips with 60 μl of SDB-RPS elution buffer (60% acetonitrile,
0.5% NH4OH (25%, HPLC grade). Samples were concentrated in a SpeedVac for
~45 min, at 45 °C, then resuspended in 7 μl MS loading buffer (0.3% TFA, 2%
acetonitrile) for mass spectrometry analysis.
We applied a label-free quantiﬁcation approach and measured samples in a
single-run format on a benchtop Orbitrap (Q Exactive HF-X) mass spectrometer72,
and all phosphoproteomics experiments were performed with four biological
replicates. Peptides were separated using an in-house packed 75 μm× 40 cm column
(1.9 μm particle size, ReproSil Pur C18-AQ) with a gradient of 3-41% ACN
containing 0.1% FA over 90min at 350 nL/min at 55 °C. The MS1 scan was acquired
from 300–1600m/z (60,000 resolution, 3e6 AGC, 120ms injection time) followed by
MS/MS data-dependent acquisition of the top 10 ions with HCD (15,000 resolution,
1e5 AGC, 50ms injection time, 27 NCE, 1.6m/z isolation width).
Raw data was processed using MaxQuant (v1.6.1.0) against the UniProt mouse
database (07/2017, 59,609 entries). Oxidation of methionine, acetylation of protein
N-terminus and phosphorylation of serine, threonine and tyrosine were set as
variable modiﬁcations. Carbamidomethylation of cysteine was set as a ﬁxed
modiﬁcation. Second peptides and match between runs options were enabled, with
the matching time window set to 1 min. FDR at the PSM, protein, and site levels
were each 1%.
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Sample preparation and mass spectrometry of total proteome. For the total
proteome study, adipocytes were triple SILAC labelled. Brieﬂy, adipocytes were
washed with ice-cold PBS and harvested in lysis buffer containing 6M urea, 2 M
thiourea, 25 mM TEAB, 0.1% SDS. After sonication, cell lysates were centrifuged at
15,000 g for 30 min at room temperature. The supernatant was precipitated using
pre-chilled acetone overnight. Protein pellets were resuspended in buffer con-
taining 6 M urea, 2 M thiourea, 25 mM TEAB. After reduction with 10 mM DTT at
room temperature for 60 min and alkylation with 25 mM IAA at room temperature
for 30 min in the dark, the protein mixture was digested using LysC (enzyme:
substrate 1:100) at 30 °C for 2 h. The protein solution was then diluted 1:5 using
25 mM TEAB and further digested with trypsin (enzyme:substrate 1:50) at 37 °C
overnight. The peptide mixture was desalted using stage-tips and separated by
HILIC system for mass spectrometry analysis. In this study, three biological
replicates were performed.
Mass spectrometry analysis was performed on the same LC/MS system
including an Easy nLC-1000 UHPLC coupled to a Q Exactive mass spectrometer
with the same method as redox proteomic analysis except that NCE was set to 27.
Raw data was processed using MaxQuant (v1.6.1.2) against the same UniProt
mouse database (06/2017, 59,581 entries). Oxidation of methionine and acetylation
of protein N-terminus were set as variable modiﬁcations. Carbamidomethylation of
cysteine was set as a ﬁxed modiﬁcation, as well as triple SILAC labels (Lys0/Arg0,
Lys4/Arg6, and Lys8/Arg10). The re-quantify, second peptides search and match
between runs options were enabled. Unique and razor peptides were used for
protein quantiﬁcation and the minimum ratio count was set to 2. Peptide match
tolerance was set to 20 ppm and 4.5 pm for ﬁrst and main searches respectively and
MS/MS match tolerance set to 20 ppm. Both PSM and protein FDR were set to 1%.
Identiﬁcation of redox PTMs on Akt by IP-MS. HEK293 cells were transfected
with FLAG-Akt2 using Lipofectamine 2000 and all studies were performed 48 h
post-transfection. Prior to IP, transfected HEK293 cells were incubated with or
without 100 μM BCNU and 1 μM auranoﬁn for 2 h. Overexpressed FLAG-Akt2
protein was puriﬁed as described previously73.To retain endogenous oxidation, no
reducing reagent was used during sample processing. In addition, the pH was
adjusted to 6.5 to minimise artiﬁcial oxidation74. Brieﬂy, cells were washed with
ice-cold PBS (pH 6.5) once and lysed in 1 mL of NP-40 buffer (1% NP-40, 10%
glycerol, 150 mM NaCl, 50 mM Tris-HCl, pH 6.5) using a 22-gauge needle six
times and then a 27-gauge needle three times followed by centrifugation at
16,000 × g for 10 min at 4 °C to remove cellular debris. Each cell lysate was incu-
bated with 40 μL slurry of protein G beads (GE Life Sciences) and 1 μL of anti-
FLAG antibody (Sigma-Aldrich; F3165) for 2 h at 4 °C with rotation. The beads
were washed three times with NP-40 buffer and twice with PBS (pH 6.5), and then
were resuspended in 40 μL of PBS (pH 6.5) containing 3xFLAG peptide (0.2 μg/μL,
Sigma-Aldrich) to elute FLAG-Akt2.
The puriﬁed FLAG-Akt2 solution was diluted using 25 mM TEAB and digested
with 1 μg trypsin at 37 °C overnight. The peptide mixture was desalted using stage-
tips. In this study, three replicates were performed.
Mass spectrometry analysis was performed on the same LC/MS system
including an Easy nLC-1000 UHPLC coupled to a Q Exactive mass spectrometer
with the same method as redox proteomic analysis except that NCE was set to 25.
Disulﬁde bonds were identiﬁed using pLink-SS as described previously74.
Five missed cleavages for trypsin digestion were allowed. Oxidation of methionine,
acetylation of protein N-terminus and Gln to pyro-Glu were set as variable
modiﬁcations. Search results were ﬁltered by requiring precursor tolerance
< 10 ppm. Only human Akt2 protein sequence was used for searching, and all
identiﬁed MS2 spectra were manually checked and labelled.
To identify the other reversible oxidative modiﬁcations on cysteines, raw data
was processed using MaxQuant (v1.5.2.10) against a UniProt human database (09/
2014) with default setting of 4.5 ppm and 20 ppm for main search precursor and
fragment ions tolerance, respectively. Oxidation of methionine and acetylation of
protein N-terminus were set as variable modiﬁcations, as well as S-Acylation, S-
Glutathionylation, S-Nitrosylation, S-Sulfenylation, S-Sulfhydration and Sulﬁnic
acid of cysteines. Two missed cleavages of speciﬁc trypsin digestion were permitted.
Both PSM and protein FDR were set to 1%.
Analysis of oxidative and total proteome and phosphoproteome. SILAC
quantiﬁcation of total proteome were log transformed (base 2), median centred,
and scaled within each treatment/condition. To characterise the changes in protein
abundance in oxidation induced cells compared to control cells, log2 fold changes
of 2 and 24 h BCNU or BCNU/AF-treated cells with respect to control cells were
estimated using Limma R package75.
Oxidative proﬁling data were analysed in a proteome-wide peptide-centric
manner in that one or more cysteine oxidation sites from a peptide were quantiﬁed
simultaneously. Quantiﬁcations were ﬁrst log transformed (base 2), median
centred, and scaled within to each treatment/condition. Centred and scaled log
quantiﬁcations from 24 h BCNU or BCNU/AF treated cells were further
normalised by dividing total protein levels from our SILAC proteome
quantiﬁcation data at the same time point (24 h) with the corresponding
treatments (BCNU or BCNU/AF) to account for changes in protein abundance.
Acute oxidative proﬁling data (2 h BCNU or BCNU/AF treatments) were excluded
from this normalisation procedure, giving that almost no changes were detected on
protein levels under 2 h treatments of either BCNU or BCNU/AF. Next, missing
values from oxidative peptides with less than 50% of missingness across samples
were imputed using a k-nearest neighbour (k= 10) imputation strategy76. Those
that have more than 50% missing values were left unchanged.
Phosphosites quantiﬁed in at least one sample were log2 transformed, median
centred, and scaled within each treatment/condition. Missing values were then
imputed for each phosphosite based on its pattern of missingness in the basal and
insulin treatments. Speciﬁcally, if phosphopeptides were quantiﬁed in at least two
out of four biological replicates in the insulin-treated samples, and no
corresponding phosphopeptide was quantiﬁed in any of the four basal samples, a
random-tail imputation procedure implemented in the Perseus environment77 was
used to simulate low values in the basal samples alone. This procedure was repeated
vice versa for basal compared to insulin samples.
Visualisation and differential expression analysis. We employed a probabilistic
principal component analysis (PCA) using EM optimisation78 to generate PCA
plots for SILAC proteome, oxidative proteome, and phosphoproteome, respec-
tively. For identifying differentially regulated proteins, oxidative peptides, and
phosphosites, normalised and imputed data from SILAC proteome, oxidative
proteome, and phosphoproteome were fed into Limma R package for differential
regulation analysis. Moderated t-test and empirical Bayesian models were used to
ﬁt each dataset and an FDR-adjusted p-value of <0.05 was used as a statistical
threshold for identifying signiﬁcantly regulated proteins, oxidative peptides, and
phosphosites. In addition, oxidative peptides regulated in 2 h or 24 h BCNU and
BCNU/AF treatments were analysed in combination using a direction-based
integrative analysis (direction pathway analysis)32 to identify concordantly up- and
downregulated oxidative peptides and those that are regulated discordantly.
Pathway analysis and functional annotation. To perform pathway analysis on
the redox proteome and phosphoproteome, we ﬁrst mapped these data in a
protein-centric manner. Speciﬁcally, oxidation and phosphorylation levels of a
given protein were quantiﬁed by the levels of oxidation and phosphorylation of the
peptides quantiﬁed from the corresponding protein in the redox proteome and
phosphoproteome experiments, respectively. For the redox proteome, proteins
concordantly up-regulated under the 2 h and 24 h BCNU/AF treatments from
direction pathway analysis32 were tested for enrichment against a Gene Ontology
database. For the phosphoproteome, over-representation analysis was performed
on phosphoproteins regulated by oxidative stress with 2 h BCNU/AF treatment in
the absence of insulin using DAVID79 (v6.8 beta, released in May/2016, https://
david-d.ncifcrf.gov/).
To further annotate function, the kinase, substrate, phosphatase, oxidative
proteome proﬁles were compared with the PhosphoSitePlus database80 and
DEPhOsphorylation database81. Speciﬁcally, proteins containing signiﬁcantly
altered oxidation site(s) by the treatment of 2 h BCNU/AF were annotated as
kinases, phosphatases, substrates of kinases, or others. To generate the circos
heatmap plot, we performed hierarchical clustering of proteins with altered
oxidation levels upon treatment with 2 h BCNU/AF and overlaid quantiﬁcation of
changes to total protein and phosphorylation levels under various treatments using
a gene-centric approach. For kinases with altered oxidation by the 2 h BCNU/AF
treatment we visualised phosphorylation proﬁles of their putative substrates
(PhosphoSitePlus) as heatmaps. For the kinases Akt, mTOR, and AMPK,
computationally predicted kinase-substrates40 were additionally utilised for
annotation. The UniProt (05/2018) annotations redox-active, interchain and other
disulﬁde forms were used to annotate oxidation sites.
Structure of Akt1 PH domain and its complex with PIP3. The crystal structure of
Akt1 PH domain was determined at 1.65 Å resolution and is available from the
protein data bank (PDB ID: 1UNP). The C60S, C77S and C77F mutations were
performed on this structure using the mutator plugin in VMD82. The WT and
mutant 1UNP structures were used in MD simulations to investigate conforma-
tional changes caused by the mutations. To study the effect of the conformational
changes on binding of PIP3, we determined the complex structures of Akt1 PH
domain and its mutants bound to PIP3 using the methods developed for toxin
binding to ion channels83. Initial poses for the complexes were obtained using the
docking program HADDOCK84, which were then reﬁned in MD simulations
where the complex structures were gradually relaxed as described below.
MD simulations. MD simulations were performed using the NAMD program85
with the CHARMM36 force ﬁeld86. An NPT ensemble with periodic boundary
conditions was employed in the MD simulations. The pressure and temperature
were maintained at 1 atm and 300 K, respectively, via Langevin coupling with
damping coefﬁcients of 5 ps−1. Lennard-Jones interactions were switched off
smoothly within a distance of 10–13.5 Å, and the particle-mesh Ewald algorithm
were applied to calculate the long-range electrostatic interactions. A time step of
2 fs was used to generate the trajectory data in MD simulations.
The simulation systems of Akt1 PH domain for both WT and mutants were
prepared using the VMD software82. Water box size for all systems were selected so
that there were at least three layers of waters between the protein and box
boundaries. The simulation box size was 102 × 89 × 106 Å3 for all systems. The
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systems were ionized and neutralized with 0.1 M of KCl solution. In MD
simulations, the systems were ﬁrst equilibrated with restrained protein atoms at
300 K to obtain the correct water density with 1 atm pressure coupling. Then
the side chain and backbone atoms were simultaneously relaxed in several steps
from k= 5 kcal/mol/Å2 to 0, simulating the systems for 200 ps at each step.
Production data were generated from 100 ns MD simulations for all systems except
for C77F, which had to be run for 200 ns due to slower equilibration of the F77 side
chain. The trajectory data were analysed using the built-in functions of VMD. The
MD simulations for the C60/77S and C77F mutant systems were replicated three
times with different initial conditions to ensure that the effect of the mutations
were reproducible. As shown in Supplementary Table 2, all three simulations
yielded similar results for the E17–R86 distances and loop 1 RMSDs, which were
used to identify the conformational changes in loop 1.
Representative images were generated using UCSF Chimera 1.14.
Soft agar assay. The soft agar assays for anchorage-independent cell growth were
performed as described previously87. Brieﬂy, 12-well plates were used and the solid
medium consisted of two layers. The bottom layer contained 0.8% noble agar and
the top layer contained 0.4% agar suspended with 2000 cells. Here, HEK293 cells
overexpressing Akt2-WT, Akt2-W80A mutant or Akt2-C60/77S-W80A mutant
were used. DMEM was added twice a week to keep the top layer moisture for the
ﬁrst week and then DMEM with 10 μM MK-2206 was used instead for the next
2 weeks. Cells were stained with 1 mg/mL iodonitrotetrazolium chloride.
Colony formation assay. HeLa cells overexpressing Akt2-WT, Akt2-W80A
mutant or Akt2-C60/77S-W80A mutant were seeded into 6-well plates (600 cells/
well) and fed for 10–12 days in DMEM containing 10% FBS and 2 mM GlutaMAX.
Cells were then treated with 10 μM MK-2206 for another 4 days. Colonies were
washed with PBS and ﬁxed (10% acetic acid, 10% methanol) for 20 min, and then
stained using 0.4% crystal violet in 20% ethanol for 20 min.
Hoechst assay. The Hoechst assays for cell proliferation were performed as
described previously88. Brieﬂy, HeLa cells overexpressing Akt2-WT, Akt2-W80A
mutant or Akt2-C60/77S-W80A mutant were seeded into 96-well plates (3,000
cells/well) and fed overnight in DMEM containing 10% FBS and 2 mM GlutaMAX.
Cells were then treated with 10 μM MK-2206 for 1 or 2 days. Media was aspirated,
and the plate was frozen at −80 °C. Plates were then thawed at room temperature
and 100 μL of water was added per well before freezing once more at −80 °C. Plates
were thawed, followed by the addition of 100 μL Hoechst-33258 solution, con-
taining 10 μg/mL Hoechst-33258 in TNE buffer (10 mM Tris-HCl, pH 7.4, 2 M
NaCl, 1 mM EDTA). The ﬂuorescence was measured at FEx= 360 nm and FEm =
440 nm.
TIRF experiments. TIRF experiments were performed as described previously53.
In brief, 3T3-L1 adipocytes at day 7 were trypsinized, electroporated with the
construct of interest and seeded onto Matrigel coated 35 mm µ-dishes (Ibidi). After
24 h, cells were incubated with basal medium (DMEM without FBS) for 2 h. Fol-
lowing this media was replaced with KRP+ buffer (KRP, 10 mM glucose and
essential amino acids) and dishes were placed onto the stage of a Nikon TiE
microscope equipped with an OKOlab microscope enclosure maintained at 37 °C.
TIRF was achieved using a Nikon hTIRF module. TagRFP-T was stimulated with a
568 nm laser angled at 71 °C and emission was captured on an Andor 888 emCCD
camera after passing through a 610/50 nm ﬁlter. Buffer switching was performed
using a custom ﬂuidic setup. Cells were treated with insulin, 100 μM BCNU and 1
μM AF, 100 μM H2O2, 50 mU/ml glucose oxidase (GOD), 10 μM diphenylene
iodinium (DPI), where added as indicated. Image data were analysed using Fiji89.
SDS-PAGE and Western blotting. Protein concentrations were determined via
BCA assay and 10 μg proteins were resolved by SDS-PAGE. The gels were trans-
ferred to PVDF membranes. Membranes were blocked in 5% skim milk powder in
TBST (0.1% Tween-20 in Tris-buffered saline) for 2 h followed by an overnight
incubation at 4 °C with indicated primary antibodies. Membranes were incubated
with an appropriate secondary antibody at room temperature for 1 h before signals
were detected using a Chemidoc or LICOR imaging system. Immunoblots were
quantiﬁed by ImageJ software and statistical signiﬁcance was assessed using Stu-
dent’s t test. All primary antibodies were used at a dilution of 1:1000 unless
otherwise stated. Secondary antibodies were used at 1:5000.
Prdx2/3 assay. Prdx2/3 assays were performed as described previously26. Brieﬂy,
cells were washed three times with ice-cold PBS containing 100 mM N-
ethylmaleimide (NEM). Cells were scraped in PBS containing 1% (w/v) SDS,
protease inhibitors and 100 mM NEM. Samples were centrifuged at 16,000 × g for
20 min at room temperature. Supernatant was collected and protein concentration
was determined. Proteins were then resolved by non-reducing SDS-PAGE and
immunoblotted using indicated antibodies.
Protein-lipid overlay assay. HEK293 cells were transfected with FLAG-Akt2 PH
domain using Lipofectamine 2000 and overexpressed FLAG-Akt2 PH domain was
puriﬁed as described above 48 h post-transfection. The puriﬁed FLAG-Akt2 PH
domain solution was made into 2 aliquots, one was incubated with 10 mM DTT at
room temperature for 20 min, and the other one was incubated with 100 μM H2O2
at room temperature for 20 min.
Protein-lipid overlay assay was performed as described previously90. Brieﬂy, a
series of lipid dilutions (ﬁnal amounts were 100, 50, 25, 10, 5 and 1 pmol,
respectively) were spotted onto nitrocellulose membranes and dried at room
temperature for 1 h. after 1 h blocking at room temperature with blocking buffer
(50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 0.1% Tween 20, 2 mg/mL fatty acid-free
BSA), the membranes were incubated with reduced or oxidized FLAG-Akt2 PH
domain in the fresh blocking buffer overnight at 4 °C. Following extensive washing,
the membranes were incubated with anti-FLAG antibody (1:1000) at room
temperature for 2 h, washed, and incubated with an appropriate secondary
antibody at room temperature for another 1 h. Signals were detected and analysed
as described above in Western blotting.
Fly stocks. The ﬂy stocks used this study were W1118 (v6000, VDRC, Vienna,
Austria), dAkt GD1361 (v2902, VDRC, Vienna, Austria), and Tubulin-Gal4/TM3-
GFP91 (gift of Essi Havula, University of Sydney, Australia). The transgenic ﬂies
created and crossed for rescue experiments are described below. All experiments
were conducted at 25 °C incubators with 65% humidity in 12L:12D cycles and ﬂies
were maintained on standard molasses food.
Genetics. UAS-hAKT2 WT and UAS-hAKT2 C60/77S were crossed with UAS-
dAKT GD1361 to generate UAS-hAKT2 WT; UAS-dAKT GD1361 and UAS-
hAKT2 C60/77S; UAS-dAKTGD1361 ﬂies.
For knockdown experiments male UAS-hAKT2 WT; UAS-dAKTGD1361 and
UAS-hAKT2 C60/77S; UAS-dAKT GD1361 were crossed to 20 Tubulin-Gal4
females. The full genotypes for these are W1118; UAS-hAKT2-WT/+; UAS-
dAKTGD1361/tubulin-GAL4 and W1118; UAS-hAKT2-WT/+; UAS-
dAKTGD1361/tubulin-GAL4.
For overexpression experiments UAS-hAKT2 WT and UAS-hAKT2 C60/77S
males were crossed directly to Tubulin-Gal4 virgins. The Full genotypes are
W1118; UAS-hAKT2 WT; +/tubulin-Gal4 and W1118; UAS-hAKT2 C60/77S;
+/tubulin-Gal4. Progeny were reared at standard density under 12L:12D at 25 °C
and allowed to mate for 48 h prior to experiments.
Length and body weight measurements. Body weight measurements of six males
and six females of each genotype were recorded from pre-blanked eppendorf tubes
weighed on a scale (Shimadzu ATX224, Tokyo, Japan). Length was measured from
micrographs taken using the Zeiss Axiocam ERs 5S mounted on the Zeiss Stemi
305 dissecting microscope (Ziess, Germany) Length measurements were traced
using ImageJ/Fiji software (NIH, Bethesda, MD, USA) and all data analysis was
performed using Excel and Prism software.
Glucose treatment for immunoblotting. Five males and females were starved
overnight (16 h) prior to being collected for immunoblotting. Following starvation,
batches of ﬂies were administered 10% glucose for 30 and 60 min. Starved and
glucose treated ﬂies were homogenized in 2% SDS buffer directly following each
treatment.
Generating UAS-hAKT2 ﬂies. We use the following primers to generate the UA
S-hAKT2 WT and UAS-hAKT2 C77/60S ﬂies: ATCTCGAGATGGACTACAAAG
ACCATGACG and ATGTTAACCAAGAAAGCTGGGTCTCACTC. The PCR
products were digested with XhoI and HpaI and ligated into pJFRC-MUH (pJFR
C-MUH was a gift from Gerald Rubin (Addgene plasmid # 26213))92. The pJFR
C-MUH-hAKT2 WT and pJFRC-MUH-hAKT2 C77/60S constructs were injected
into y1 w67c23; P{CaryP}attP40 strain embryos (Bestgene, Chino Hills, CA, USA).
Redox state of Akt Cys60-Cys77 disulﬁde bond in ﬁbroblasts. Full-length
human Akt1 containing an N-terminal hemagglutinin (HA) tag was expressed in
NIH/3T3 ﬁbroblasts using lentivirus. Serum-starved cells (2.5 × 106) were incu-
bated with 10 nM human insulin for up to 60 min. At discrete times, whole cell
lysates were prepared in phosphate-buffered saline containing 5 mM EDTA, pro-
tease inhibitor cocktail (Roche), phosphatase inhibitor (Roche) and 5 mM 2-iodo-
N-phenylacetamide (12C-IPA, Cambridge Isotopes) to alkylate the unpaired Cys
thiols in Akt1. Akt1 was immunoprecipitated from lysates using an anti-HA
antibody (ThermoFisher Scientiﬁc, 26183) and protein G dynabeads and resolved
on SDS-PAGE. The Akt1 band was excised, disulﬁde bonds in the protein reduced
with dithiothreitol and the new unpaired Cys thiols labelled with a stable carbon-13
isotope of IPA (13C-IPA). The protein was digested with trypsin, cysteine-
containing peptides resolved on liquid chromatography and their identity deter-
mined by mass spectrometry (Supplementary Fig. 7). The redox state of the
cysteines was calculated from the relative ion abundance of 2–4 peptides labelled
with 12C-IPA and/or 13C-IPA as we have described93,94.
Mechanistic modelling. The mechanistic Akt model was formulated using
ordinary differential equations (ODEs). The model’s schematic diagram containing
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all model reactions is given in Fig. 7c. The model was implemented in Matlab and
model ﬁtting was performed using genetic algorithms as part of Matlab’s Opti-
misation Toolbox. Detailed description of model equations, model ﬁtting proce-
dure and parameter values used for simulations are given in the Supplementary
Note 1 and Supplementary Tables 3-5.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
Data supporting the ﬁndings of this manuscript are available from the corresponding
author upon reasonable request. A reporting summary for this Article is available as a
Supplementary Information ﬁle. The source data underlying Figs. 1b–g, 2b–d, 3, 4c–e, 3b,
c, 4a–e, g, i, k–n, 5d–l, 6a–i, k, 7a, b, d, e, f, h, i and Supplementary Figs. 1c, d, 2a–g, 3a–d,
5a–i, 6a–g are provided as a Source Data ﬁle. All MS data have been deposited to the
ProteomeXchange Consortium via the PRIDE partner repository95 with the dataset
identiﬁer PXD011525.
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